7-44150869-T-G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000162.5(GCK):​c.483+87A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.506 in 1,601,364 control chromosomes in the GnomAD database, including 208,743 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★). The gene GCK is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.57 ( 25911 hom., cov: 33)
Exomes 𝑓: 0.50 ( 182832 hom. )

Consequence

GCK
NM_000162.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.37

Publications

14 publications found
Variant links:
Genes affected
GCK (HGNC:4195): (glucokinase) This gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, this enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of this gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, this enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, this enzyme is important in glucose uptake and conversion to glycogen. Mutations in this gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia. [provided by RefSeq, Aug 2017]
GCK Gene-Disease associations (from GenCC):
  • hyperinsulinism due to glucokinase deficiency
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • maturity-onset diabetes of the young type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • monogenic diabetes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • diabetes mellitus, noninsulin-dependent
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • permanent neonatal diabetes mellitus 1
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • transient neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • maturity-onset diabetes of the young
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • permanent neonatal diabetes mellitus
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 7-44150869-T-G is Benign according to our data. Variant chr7-44150869-T-G is described in ClinVar as Benign. ClinVar VariationId is 676858.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.734 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000162.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCK
NM_000162.5
MANE Select
c.483+87A>C
intron
N/ANP_000153.1Q53Y25
GCK
NM_033507.3
c.486+87A>C
intron
N/ANP_277042.1P35557-2
GCK
NM_033508.3
c.480+87A>C
intron
N/ANP_277043.1P35557-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GCK
ENST00000403799.8
TSL:1 MANE Select
c.483+87A>C
intron
N/AENSP00000384247.3P35557-1
GCK
ENST00000395796.8
TSL:1
n.*481+87A>C
intron
N/AENSP00000379142.4A0A8C8KJG0
GCK
ENST00000671824.1
c.483+87A>C
intron
N/AENSP00000500264.1A0A5F9ZHE0

Frequencies

GnomAD3 genomes
AF:
0.573
AC:
87106
AN:
151982
Hom.:
25887
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.741
Gnomad AMI
AF:
0.501
Gnomad AMR
AF:
0.568
Gnomad ASJ
AF:
0.501
Gnomad EAS
AF:
0.634
Gnomad SAS
AF:
0.437
Gnomad FIN
AF:
0.493
Gnomad MID
AF:
0.472
Gnomad NFE
AF:
0.495
Gnomad OTH
AF:
0.559
GnomAD4 exome
AF:
0.499
AC:
723248
AN:
1449266
Hom.:
182832
AF XY:
0.496
AC XY:
357698
AN XY:
720986
show subpopulations
African (AFR)
AF:
0.745
AC:
24721
AN:
33204
American (AMR)
AF:
0.594
AC:
26288
AN:
44286
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
12870
AN:
25922
East Asian (EAS)
AF:
0.636
AC:
25064
AN:
39414
South Asian (SAS)
AF:
0.430
AC:
36716
AN:
85306
European-Finnish (FIN)
AF:
0.499
AC:
25965
AN:
51982
Middle Eastern (MID)
AF:
0.470
AC:
2397
AN:
5100
European-Non Finnish (NFE)
AF:
0.488
AC:
539104
AN:
1104306
Other (OTH)
AF:
0.504
AC:
30123
AN:
59746
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
18962
37925
56887
75850
94812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15954
31908
47862
63816
79770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.573
AC:
87174
AN:
152098
Hom.:
25911
Cov.:
33
AF XY:
0.572
AC XY:
42507
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.741
AC:
30743
AN:
41492
American (AMR)
AF:
0.568
AC:
8679
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.501
AC:
1738
AN:
3468
East Asian (EAS)
AF:
0.633
AC:
3277
AN:
5174
South Asian (SAS)
AF:
0.435
AC:
2099
AN:
4822
European-Finnish (FIN)
AF:
0.493
AC:
5218
AN:
10574
Middle Eastern (MID)
AF:
0.473
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
0.495
AC:
33645
AN:
67958
Other (OTH)
AF:
0.558
AC:
1180
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1888
3776
5665
7553
9441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
726
1452
2178
2904
3630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.538
Hom.:
3753
Bravo
AF:
0.589
Asia WGS
AF:
0.524
AC:
1822
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.37
DANN
Benign
0.43
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2268573; hg19: chr7-44190468; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.